Irinotecan Hydrochloride - irinotecan hydrochloride
Navigation: NDC > Supplier starting with: S > SAGENT PHARMACEUTICALS| Field | Value |
|---|---|
| NDC Code: | 25021-214 |
| Proprietary Name: | Irinotecan Hydrochloride |
| Suffix: | |
| Non-Proprietary Name: | irinotecan hydrochloride |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 20-04-2012 |
| Category Name: | ANDA |
| Application Number: | ANDA078589 |
| Labeler: | SAGENT PHARMACEUTICALS |
| Substance Name: | IRINOTECAN HYDROCHLORIDE |
| Active Numerator Strength: | 20 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| DEA Schedule: |